Nephro-Urology Monthly

Published by: Kowsar

IgM nephropathy revisited

Muhammed Mubarak 1 , * and Javed Kazi 1
Authors Information
1 Histopathology Department, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
Article information
  • Nephro-Urology Monthly: September 01, 2012, 4 (4); 603-608
  • Published Online: September 26, 2012
  • Article Type: Review Article
  • Received: October 13, 2011
  • Revised: November 2, 2011
  • Accepted: November 27, 2011
  • DOI: 10.5812/numonthly.2805

To Cite: Mubarak M, Kazi J. IgM nephropathy revisited, Nephro-Urol Mon. 2012 ; 4(4):603-608. doi: 10.5812/numonthly.2805.

Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Definition
3. History
4. Epidemiology
5. Etiology
6. Pathogenesis
7. Pathology
8. Clinical Features
9. Natural History and Prognosis
10. Treatment
11. Conclusions
  • 1. Mubarak M, Kazi JI, Shakeel S, Lanewala A, Hashmi S, Akhter F. Clinicopathologic characteristics and steroid response of IgM nephropathy in children presenting with idiopathic nephrotic syndrome. APMIS. 2011; 119(3): 180-6[DOI][PubMed]
  • 2. Cohen AH, Border WA, Glassock RJ. Nehprotic syndrome with glomerular mesangial IgM deposits. Lab Invest. 1978; 38(5): 610-9[PubMed]
  • 3. Bhasin HK, Abuelo JG, Nayak R, Esparza AR. Mesangial proliferative glomerulonephritis. Lab Invest. 1978; 39(1): 21-9[PubMed]
  • 4. Lawler W, Williams G, Tarpey P, Mallick NP. IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol. 1980; 33(11): 1029-38[DOI][PubMed]
  • 5. Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, et al. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. Histopathology. 1984; 8(3): 435-46[DOI][PubMed]
  • 6. Cavallo T, Johnson MP. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron. 1981; 27(6): 281-4[DOI][PubMed]
  • 7. Mampaso F, Gonzalo A, Teruel J, Losada M, Gallego N, Ortuno J, et al. Mesangial deposits of IgM in patients with the nephrotic syndrome. Clin Nephrol. 1981; 16(5): 230-4[PubMed]
  • 8. Chan YH, Wong KM, Choi KS, Chak WL, Cheung CY. Clinical manifestation and progression of IgM mesangial nephropathy: a single center perspective. Hong Kong J Nephrol. 2000; 2: 23-6[DOI]
  • 9. Border WA. Distinguishing minimal-change disease from mesangial disorders. Kidney Int. 1988; 34(3): 419-34[DOI][PubMed]
  • 10. van de Putte LB, de la Riviere GB, van Breda Vriesman PJ. Recurrent or persistent hematuria. Sign of mesangial immune-complex deposition. N Engl J Med. 1974; 290(21): 1165-70[DOI][PubMed]
  • 11. Helin H, Mustonen J, Pasternack A, Antonen J. IgM-associated glomerulonephritis. Nephron. 1982; 31(1): 11-6[DOI][PubMed]
  • 12. Saha H, Mustonen J, Pasternack A, Helin H. Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol. 1989; 9(2): 124-8[DOI][PubMed]
  • 13. Myllymaki J, Saha H, Mustonen J, Helin H, Pasternack A. IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis. 2003; 41(2): 343-50[DOI][PubMed]
  • 14. Kazi JI, Mubarak M, Malik SS. Clinicopathologic study of IgM nephropathy in children presenting with idiopathic nephrotic syndrome in Pakistan. J Pak Med Assoc. 2010; 60(10): 878-9[PubMed]
  • 15. Donia AF, Sobh MA, Moustafa FE, Bakr MA, Foda MA. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians. J Nephrol. 2000; 13(4): 275-81[PubMed]
  • 16. Hamed RM. Clinical significance and long-term evolution of mesangial proliferative IgM nephropathy among Jordanian children. Ann Saudi Med. 2003; 23(5): 323-7[PubMed]
  • 17. Jungthirapanich J, Singkhwa V, Watana D, Futrakul P, Sensirivatana R, Yenrudi S. Significance of tubulointerstitial fibrosis in paediatric IgM nephropathy. Nephrology. 1997; 3: 509-14[DOI]
  • 18. Singhai AM, Vanikar AV, Goplani KR, Kanodia KV, Patel RD, Suthar KS, et al. Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: a single-center study of natural history. Indian J Pathol Microbiol. 2011; 54(1): 3-6[DOI][PubMed]
  • 19. Salmon AH, Kamel D, Mathieson PW. Recurrence of IgM nephropathy in a renal allograft. Nephrol Dial Transplant. 2004; 19(10): 2650-2[DOI][PubMed]
  • 20. Mokhtar GA. IgM nephropathy: clinical picture and pathological findings in 36 patients. Saudi J Kidney Dis Transpl. 2011; 22(5): 969-75[PubMed]
  • 21. Disciullo SO, Abuelo JG, Moalli K, Pezzullo JC. Circulating heavy IgM in IgM nephropathy. Clin Exp Immunol. 1988; 73(3): 395-400[PubMed]
  • 22. Kishimoto H, Arakawa M. Clinico-pathological characterization of mesangial proliferative glomerulonephritis with predominant deposition of IgM. Clin Exp Nephrol. 1999; 3(2): 110-5[DOI]
  • 23. Zeis PM, Kavazarakis E, Nakopoulou L, Moustaki M, Messaritaki A, Zeis MP, et al. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children. Pediatr Int. 2001; 43(3): 287-92[DOI][PubMed]
  • 24. Al-Eisa A, Carter JE, Lirenman DS, Magil AB. Childhood IgM nephropathy: comparison with minimal change disease. Nephron. 1996; 72(1): 37-43[DOI][PubMed]
  • 25. O’Donoghue DJ, Lawler W, Hunt LP, Acheson EJ, Mallick NP. IgM-associated primary diffuse mesangial proliferative glomerulonephritis: natural history and prognostic indicators. Q J Med. 1991; 79(288): 333-50[PubMed]
  • 26. Pardo V, Riesgo I, Zilleruelo G, Strauss J. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis. 1984; 3(4): 264-9[PubMed]
  • 27. Ji-Yun Y, Melvin T, Sibley R, Michael AF. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int. 1984; 25(1): 100-6[DOI][PubMed]
  • 28. Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M. Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular “immune deposits”. Pediatr Nephrol. 1988; 2(4): 402-8[DOI][PubMed]
  • 29. Betjes MG, Roodnat JI. Resolution of IgM nephropathy after rituximab treatment. Am J Kidney Dis. 2009; 53(6): 1059-62[DOI][PubMed]
  • 30. Westphal S, Hansson S, Mjornstedt L, Molne J, Swerkersson S, Friman S. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Transplant Proc. 2006; 38(8): 2659-60[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments